GLP-1 Drugs Cost Nearly 1 In 5 Users At Least 10% Of Household Income

People are less likely to take their GLP-1s when they cost more

“The key takeaway from our study is that out-of-pocket costs matter.”

GLP-1 Drugs Cost Nearly 1 In 5 Users At Least 10% Of Household Income

Nearly one in five GLP-1 users spend 10% or more of household income on the drugs, and lower-income adults feel it most.

How much do Americans spend on GLP-1 medications? Medical students measure drug affordability

The number of people using GLP-1 treatments like Ozempic and Wegovy for weight loss or chronic conditions has increased rapidly, with more than 1 in 10 U.S. adults currently taking such medications. A new study led by medical students at Virginia Commonwealth University has shed light on how this rise in GLP-1 drug use is affecting Americans' wallets.